The importance of community and civil society engagement to end TB has been highlighted in various strategies of global commitments. The WHO End TB Strategy, aligned with the United Nations Sustainable Development Goals, emphasizes the role of communities and civil society in ending the TB epidemic by 2030. Furthermore, the political declaration of the 2081 United Nations High-level Meeting on TB Highlights the need to develop integrated, people-centred, community-based, gender-responsive health services. This guidance was developed in collaboration with civil society and other partners, in order to further strengthen engagement and leverage capacities of communities' and civil society in line with the End TB Strategy. The guidance emphasizes the complementarity of health systems and community systems; the key roles that people affected by TB should play in planning, decision-making, implementation and monitoring; and the role of ministries of health and their NTPs. It underlines the importance of fair, sustainable financing and of policy environment for community and civil society engagement. Its purpose is to provide guidance for communities and for all stakeholders in the health system for working together to end TB and strengthening people-centred care. Stakeholders in national TB responses include ministries of health, other government ministries, the private sector, civil society and affected communities, academic and research institutions, and technical and funding partners.

The Operational guidance on adaptation and implementation of WHO’s Multisectoral Accountability Framework to end TB (MAF-TB) provides practical advice on key approaches and interventions needed to establish the MAF-TB at the national (and local) levels with concrete country examples, best practices and case studies under each suggested approach and interventions. It is intended for use by all stakeholders involved in their national TB response, including ministries of health and other relevant government ministries and bodies, national TB programmes (or their equivalents in ministries of health), other relevant national programmes, parliamentarians, the private sector, international organizations, nongovernmental and civil society organizations and TB-affected communities involved in planning, implementation, monitoring and evaluation and review of the TB response. The stakeholders involved may vary across countries depending on several factors, including the epidemiology and determinants of TB, the institutional arrangements for TB care and prevention and the degree of devolution of the political and health governance system.

A national strategic plan (NSP) for TB is a key document that guides national authorities and stakeholders on how to comprehensively address the TB epidemic through interventions within the health and across other sectors. The NSP translates global, regional and national commitments into national and subnational targets and activities to be implemented to achieve these targets, and provides the basis for mobilizing domestic and external resources for the TB response. It outlines the overall goal(s), strategies and priority interventions, and provides guidance on how these are coordinated across sectors. This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed structure of the NSP. The target audience of this publication are all stakeholders involved in national strategic planning for TB (e.g., ministry of health, other government ministries, private sector, civil society, affected communities, academic and research institutions, and technical and funding partners). The current document is an update to the 2015 Toolkit to develop a national strategic plan for TB prevention, care and control. It was developed to better align with global commitments and latest developments in TB and in public health, and builds on lessons learned from using the 2015 toolkit.

The purpose of this document is to describe and explain how to apply the principles of good clinical practices (GCP) and good data management practices (GDMP) in the context of national tuberculosis (TB) surveys, namely national population-based surveys of TB prevalence, anti-TB drug resistance surveys, and surveys of costs faced by TB patients and their households. The primary target audience for this handbook includes national TB programmes (NTPs) and partners involved in the planning, design, conduct, oversight, analysis and reporting of a national TB survey. The in-country national survey coordination team is responsible for ensuring that all survey team members conform to this guidance document.